Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum MERUS LABS INTERNATIONAL INC T.MSL

"Merus Labs International Inc is a specialty pharmaceutical company. The Company acquires and licenses novel pharmaceutical products."

TSX:MSL - Post Discussion

MERUS LABS INTERNATIONAL INC > ebitda emphasis is sort changing the co.
View:
Post by lscfa on Feb 14, 2017 8:33pm

ebitda emphasis is sort changing the co.

ebitda does not give co. credit for low interest rate and low tax rate so market is mis-valuing the stock.


Current adj ebitda $10.85 mil
Annualized = $43.4 mil
EV/ ebitda multiple of 6 => $260.4 mil
Less net debt of $136.5 mil => equity of $124 mil
117 mil shs. => $1.06
 
Current adj. eps = $0.062
Annualized = $0.248
p/e multiple of 8 => $1.98

net loss   -6,317,410
fx losses (gains) 3,748,357
amort of intangibles 8,941,592
legal settlement 998,176
acquisition costs 0
derivative losses (gains) -77,410
adj net income 7,293,305
shs avg o/s 116,999,906
adj eps   $0.062
Comment by lscfa on Feb 28, 2017 3:44pm
Let's hope mgmt is not dumb enough to let a buyer price a takeover on EBITDA multiples.....
Comment by peter75 on Feb 28, 2017 4:53pm
Good work I came up with 1.85 without factoring tax carry Feds that are worth money
Comment by lscfa on Feb 28, 2017 8:14pm
The example used trailing no.s for comparision purposes only....we know that Q4 ebitda is to be 25% higher than Q1 editda, so 1.25 x $10.85 = $13.56 for a $54.25 million annualized run rate EV / ebitda multiple of 7 => $380 mil EV less debt of $136.5 => $243.25 mkt cap 117 mil shs. => $2.08
Comment by Kensin1953 on Feb 28, 2017 9:46pm
$2.08 exactly    I had to laugh when I saw this    T.IRD   i guess I don't get out much
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities